DFC

Cidara Therapeutics Named as a San Diego Metro Area Top Workplace

Retrieved on: 
Monday, November 20, 2023

SAN DIEGO, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today announced that it has been named a Top Workplace by The San Diego Union-Tribune.

Key Points: 
  • SAN DIEGO, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, today announced that it has been named a Top Workplace by The San Diego Union-Tribune.
  • Cidara was among the top 100 companies and organizations included in the 2023 Top Workplace list.
  • “We are proud to once again be considered one of the best places to work in San Diego,” said Jeffrey Stein, Ph.D. president and chief executive officer of Cidara.
  • The San Diego Union-Tribune published the complete list of 2023 Top Workplaces on Sunday, November 19, 2023.

TechMet Announces Cornerstone Investment from S2G Ventures in its $300M Equity Raise

Retrieved on: 
Thursday, December 7, 2023

S2G Ventures (“S2G”) has today announced its second investment in the leading critical minerals investment company, TechMet, which is now valued at more than $1 billion.

Key Points: 
  • S2G Ventures (“S2G”) has today announced its second investment in the leading critical minerals investment company, TechMet, which is now valued at more than $1 billion.
  • View the full release here: https://www.businesswire.com/news/home/20231206826064/en/
    S2G's Chief Investment Officer and Senior Managing Director Sanjeev Krishnan with TechMet Chairman and CEO Brian Menell at COP28.
  • The deal brings S2G’s investment in TechMet to $50M.
  • Earlier this week (Dec 3), a commitment letter for the extra $50M equity investment in TechMet was signed by the DFC’s CEO Scott Nathan at a signing ceremony held at COP28.

TechMet Receives further $50 Million Commitment From U.S. International Development Finance Corporation at COP28

Retrieved on: 
Friday, December 1, 2023

TechMet , a global critical minerals investment company, has secured a further $50 million commitment from the U.S. International Development Finance Corporation (DFC) as part of its latest fundraising round.

Key Points: 
  • TechMet , a global critical minerals investment company, has secured a further $50 million commitment from the U.S. International Development Finance Corporation (DFC) as part of its latest fundraising round.
  • The additional commitment from the U.S. Government’s development finance institution comes as TechMet opens a new $300 million equity funding round.
  • DFC is already a key shareholder in TechMet and this will raise its total investment to $105 million, following an initial investment in 2020.
  • TechMet, founded in 2017, is an investment company focused on building businesses across the critical metals value chain, from extraction and processing to recycling and supply-chain management.

Impact Disclosure Taskforce Created to Scale Financing of the United Nations Sustainable Development Goals

Retrieved on: 
Tuesday, November 28, 2023

The Taskforce also intends to explore mechanisms for disseminating and analyzing this entity-level impact information to promote transparency and accountability.

Key Points: 
  • The Taskforce also intends to explore mechanisms for disseminating and analyzing this entity-level impact information to promote transparency and accountability.
  • The Taskforce also obtains input from public development banks including the Asian Development Bank (ADB), the French Agency for Development (AFD), and the United States International Development Finance Corporation (DFC), as well as from the Global Impact Investing Network (GIIN), members of the Global Investors for Sustainable Development Alliance (GISD), and Linklaters.
  • Collaborating to provide suggested guidance on standardized impact metrics for development finance will allow entities to more clearly communicate their contribution towards the SDGs.
  • We are working to support greater impact disclosures and ultimately attract more sustainable finance capital to emerging markets and developing countries.”

Allied Climate Partners Launches to Catalyze Bankable Climate-Related Projects in Emerging Economies

Retrieved on: 
Friday, December 1, 2023

Allied Climate Partners' mission is to increase the number of bankable, climate-related projects and businesses in emerging economies to create significant environmental, economic, and social impact.

Key Points: 
  • Allied Climate Partners' mission is to increase the number of bankable, climate-related projects and businesses in emerging economies to create significant environmental, economic, and social impact.
  • "Local leaders around the world have identified a clear problem: there simply aren't enough bankable climate-related projects to deploy capital at the scale we need to address the climate crisis," said Allied Climate Partners CEO Ahmed Saeed.
  • The lack of bankable projects has long stifled climate investment in developing nations, particularly in the precarious early stages of project development.
  • That's where Allied Climate Partners comes in," said Andrew Steer, President & CEO of the Bezos Earth Fund.

$13.5M DEVELOPMENT IMPACT BOND FOR REFUGEES EXCEEDS EXPECTATIONS

Retrieved on: 
Wednesday, November 29, 2023

AMMAN, Jordan, Nov. 29, 2023 /PRNewswire/ -- The IKEA Foundation, Novo Nordisk Foundation, Norad, the U.S. International Development Finance Corporation (DFC), Ferd, and KOIS have received its first payment-linked evaluation results of the 'Refugee Impact Bond' (DIB) launched in Jordan in October 2021. The DIB funds a micro-enterprise creation program delivered by Near East Foundation (NEF) to help vulnerable Jordanians and Syrian refugees recover their livelihoods and build their resilience. 

Key Points: 
  • The DIB funds a micro-enterprise creation program delivered by Near East Foundation (NEF) to help vulnerable Jordanians and Syrian refugees recover their livelihoods and build their resilience.
  • In May and June 2023, the Refugee DIB's independent evaluator, Mathematica, surveyed a sample of grantees from the program's first cohort.
  • The survey measured various outcomes related to grantees' businesses, as well as their employment status and income from employment.
  • The payment metric was high across demographic subgroups, remaining above 98 percent for both genders, refugees and Jordanians, and youth and adults.

Dairy Farmers of Canada's Award-Winning Sustainability Campaign Recognized Again by Global Community

Retrieved on: 
Wednesday, November 29, 2023

OTTAWA, ON, Nov. 28, 2023 /CNW/ - Dairy Farmers of Canada (DFC)'s award-winning marketing campaign to promote the sustainability efforts of dairy farmers has been further recognized by the global community.

Key Points: 
  • OTTAWA, ON, Nov. 28, 2023 /CNW/ - Dairy Farmers of Canada (DFC)'s award-winning marketing campaign to promote the sustainability efforts of dairy farmers has been further recognized by the global community.
  • "We are grateful to once again accept international recognition for this great campaign that captures the hard work and dedication Canadian dairy farmers have made towards sustainability," said David Wiens, president of Dairy Farmers of Canada.
  • In June, the campaign won two World Dairy Innovation Awards in the CSR/Sustainability Initiative category and the Marketing Campaign category at the Global Dairy Congress in London, England.
  • Dairy farmers have set a goal of net-zero emissions from farm-level dairy production by 2050.

U.S. International Development Finance Corporation, America’s Development Finance Institution, to Fund CWIT, Adani’s JV in Sri Lanka, for USD 553 Million

Retrieved on: 
Wednesday, November 8, 2023

U.S. International Development Finance Corporation (DFC) has announced that it will be funding Colombo West International Terminal Pvt.

Key Points: 
  • U.S. International Development Finance Corporation (DFC) has announced that it will be funding Colombo West International Terminal Pvt.
  • Ltd. (CWIT) – a consortium of India's largest port operator Adani Ports and SEZ Ltd., Sri Lanka's leading enterprise John Keells Holdings (JKH) and the Sri Lanka Ports Authority – to the tune of USD 553 million.
  • View the full release here: https://www.businesswire.com/news/home/20231107733135/en/
    U.S. International Development Finance Corporation, America’s Development Finance Institution, to Fund CWIT, Adani’s JV in Sri Lanka, for USD 553 Million (Photo: Business Wire)
    DFC, the U.S. government’s development finance institution, partners with the private sector to finance solutions to the most critical challenges facing the developing world.
  • “Sri Lanka is one of the world’s key transit hubs, with half of all container ships transiting through its waters.

Cidara Therapeutics Presents Preclinical Data on Novel Drug-Fc Conjugate CBO421 at SITC’s 38ᵗʰ Annual Meeting

Retrieved on: 
Friday, November 3, 2023

The conference is taking place November 1-5, 2023, both virtually and in-person in San Diego, CA.

Key Points: 
  • The conference is taking place November 1-5, 2023, both virtually and in-person in San Diego, CA.
  • “We look forward to sharing data that demonstrate the potential for CBO421 to potently inhibit tumor growth as both a monotherapy and in combination with PD-1 therapies,” said Jeffrey Stein, Ph.D. president and chief executive officer of Cidara.
  • “CD73 plays a significant role in contributing to immune evasion in solid tumors.
  • Based on these data, we’re excited to advance this candidate into clinical trials for the treatment of solid tumors.”
    Presentation details are summarized below:

Cidara Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results

Retrieved on: 
Thursday, November 2, 2023

Nicole is a practicing oncology physician and joins us from Genentech/Roche where she has had substantial cancer-focused product development experience.

Key Points: 
  • Nicole is a practicing oncology physician and joins us from Genentech/Roche where she has had substantial cancer-focused product development experience.
  • Presented at IDWeek 2023: In September 2023, Cidara delivered an oral presentation and two poster presentations highlighting the safety and efficacy of CD388.
  • For the nine months ended September 30, 2023 and 2022, net loss was $17.3 million and $16.4 million, respectively.
  • During the three months ended September 30, 2023, Cidara did not sell shares of common stock pursuant to its at-the-market (ATM) sales agreement.